Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Sean M. Healey & AMG Center for ALS
The HEALEY ALS Platform Trial led by the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) today announced topline results from Regimen C evaluating CMN-Au8, developed by Clene Nanomedicine, Inc.
Learn MoreA research group including several Healey Center investigators has a new report with promising results on the use of the experimental drug Toferson.
Clinical Leader highlights advances in ALS research, including the HEALEY ALS Platform Trial and BrainGate.
Join our quest to discover life-saving therapies for individuals who are affected by ALS. The key to our success is our dedication to collaboration. At the Sean M. Healey and AMG Center for ALS at Mass General, we partner with the best clinician-scientists, our patients and friends like you to turn laboratory successes into promising therapies.
